Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05968924 · ClinicalTrials.gov registry record · NA

Improving DFU Outcomes: Early Detection of Foot Ulcers Using Novel Technology

A NA study, sponsored by Montefiore Medical Center.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT05968924: Completed NA study, sponsored by Montefiore Medical Center.

NCT05968924 is a NA study that has completed, run by Montefiore Medical Center. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05968924, a NA study, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The investigator team will study the adherence of the participant cohort to a non significant risk device over a six month period. The device is a foot mat, which can detect changes in foot temperature that may predict foot ulceration in patients with diabetes mellitus. This mat, the Podimetrics Smart Mat, is FDA cleared.

Primary Outcome

Participant adherence to use of SmartMat will be quantified by automated data collection. Adherence is defined as having conducted \>3 days foot scans per week (foot scans/week) over the six-month period. The median number of scans/week over a six-month period is reported.

Interventions

  • DEVICE Podimetrics SmartMat

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-07-03
Est. Completion 2025-04-03
Phase NA
Montefiore Medical Center

345 total trials

What the finished NCT05968924 record still lists

NCT05968924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Podimetrics SmartMat is the first listed.

NCT05968924 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05968924 about?

NCT05968924 is a clinical study titled "Improving DFU Outcomes: Early Detection of Foot Ulcers Using Novel Technology". The investigator team will study the adherence of the participant cohort to a non significant risk device over a six month period. The device is a foot mat, which can detect changes in foot temperature that may predict foot ulceration in patients with diabetes mellitus. This mat, the Podimetrics Sma...

What is the current status of trial NCT05968924?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-07-03. Estimated completion is 2025-04-03.

What interventions are being tested in trial NCT05968924?

The interventions under investigation include: Podimetrics SmartMat (DEVICE).

Who is sponsoring clinical trial NCT05968924?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05968924's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05968924, the US trial registry maintained by the National Library of Medicine. NCT05968924 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.